Merck shares rise after saying cholesterol drug met primary goal in study
June 27, 2017 at 08:22 AM EDT
Merck said Tuesday its cholesterol drug anacetrapib met its primary goal in significantly reducing coronary heart disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.